In a first-ever systemic review of its kind, researchers at Boston University Center for Global Health and Development estimate the average rates of retention in antiretroviral therapy in pediatric patients from low- and middle-income countries is similar to retention rates for adults--declining from 88% after 12 months to 67% after 36 months. Follow the link below to read the full article. This high rate of attrition for children is concerning considering that "pediatric disease progression tends to occur faster than for adults in the absence of treatment." Interventions to address this high attrition rate seen in pediatric populations are needed in order to increase survival, especially when treatment is started early. Follow the link below to see the full article.